Trades on 1 secondary market
Manifold Bio
Manifold Bio is a biotechnology company developing tissue-targeted biologic medicines. It runs a high-throughput in vivo discovery engine that pairs massively multiplexed in vivo screening — using mCode protein barcodes read out by DNA sequencing — with AI-powered protein and antibody design (mBER)
Manifold Bio is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.